Celldex Therapeutics Inc.

NASDAQ:CLDX   10:17:34 AM EDT
36.85
+1.17 (+3.28%)
Earnings Announcements

Celldex Posts Q3 Loss Per Share Of $0.45

Published: 11/09/2021 21:58 GMT
Celldex Therapeutics Inc. (CLDX) - Celldex Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.45.
Q3 Earnings per Share View $-0.36 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $1.04 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $0.65 Million
Next Quarter EPS Guidance is expected to be -$0.42

More details on our Analysts Page.